Gene · 871
Papers3,090
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,090
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biological and molecular characterization of fEg-Eco19, a lytic bacteriophage active against an antibiotic-resistant clinical Escherichia coli isolate. | Arch Virol | 2022 | 35399144 | PubTator, text mining | PubMed |
| Development of iPSC-based clinical trial selection platform for patients with ultrarare diseases. | Sci Adv | 2022 | 35394834 | PubTator, text mining | PubMed |
| Osteoporosis in children and adolescents: when to suspect and how to diagnose it. | Eur J Pediatr | 2022 | 35384509 | PubTator, text mining | PubMed |
| Physical and functional interactome atlas of human receptor tyrosine kinases. | EMBO Rep | 2022 | 35384245 | PubTator, text mining | PubMed |
| LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma. | Cell | 2022 | 35381199 | PubTator, text mining | PubMed |
| Cellular and transcriptional diversity over the course of human lactation. | Proc Natl Acad Sci U S A | 2022 | 35377806 | PubTator, text mining | PubMed |
| Clinical practice guidelines for optimizing bone health in Korean children and adolescents. | Ann Pediatr Endocrinol Metab | 2022 | 35368191 | PubTator, text mining | PubMed |
| Milk Transmission of HTLV-1 and the Need for Innovative Prevention Strategies. | Front Med (Lausanne) | 2022 | 35360738 | PubTator, text mining | PubMed |
| Development, Pathogenesis, and Regeneration of the Intervertebral Disc: Current and Future Insights Spanning Traditional to Omics Methods. | Front Cell Dev Biol | 2022 | 35359439 | PubTator, text mining | PubMed |
| [Bioinformatic analysis of immune correlation and prognostic value of SERPINs in glioma]. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2022 | 35356880 | PubTator, text mining | PubMed |
| Topical heparin as an effective and safe treatment for patients with capecitabine-induced hand-foot syndrome: results of a phase IIA trial supported by proteomic profiling of skin biopsies. | Ther Adv Med Oncol | 2022 | 35356259 | PubTator, text mining | PubMed |
| Intra-Specific Diversity of Leishmania major Isolates: A Key Determinant of Tunisian Zoonotic Cutaneous Leishmaniasis Clinical Polymorphism. | Microorganisms | 2022 | 35336081 | PubTator, text mining | PubMed |
| Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. | J Hematol Oncol | 2022 | 35331296 | PubTator, text mining | PubMed |
| Molecular Mechanisms Involved in Hypoxia-Induced Alterations in Bone Remodeling. | Int J Mol Sci | 2022 | 35328654 | PubTator, text mining | PubMed |
| Phenotypic Variation in Vietnamese Osteogenesis Imperfecta Patients Sharing a Recessive P3H1 Pathogenic Variant. | Genes (Basel) | 2022 | 35327962 | PubTator, text mining | PubMed |
| Clinical Applications of Short Non-Coding RNA-Based Therapies in the Era of Precision Medicine. | Cancers (Basel) | 2022 | 35326738 | PubTator, text mining | PubMed |
| FOXO3 Expression in Macrophages Is Lowered by a High-Fat Diet and Regulates Colonic Inflammation and Tumorigenesis. | Metabolites | 2022 | 35323693 | PubTator, text mining | PubMed |
| Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics. | J Inflamm Res | 2022 | 35310454 | PubTator, text mining | PubMed |
| CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma. | World J Surg Oncol | 2022 | 35307012 | PubTator, text mining | PubMed |
Tyrosine-sulfated dermatopontin shares multiple binding sites and recognition determinants on triple-helical collagens with proteins implicated in cell adhesion and collagen folding, fibrillogenesis, cross-linking, and degradation. | Biochim Biophys Acta Proteins Proteom | 2022 | 35306228 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/871/papers?page=38